Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-05 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.220 | -0.0500 | ||||
REV | 16.960M | 19.333M | 2.373M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
PGEN | Precigen | 8.45 | 0.26 | 3.17% | 1.7B |
You can purchase shares of Precigen (NASDAQ: PGEN) through any online brokerage.
Other companies in Precigen’s space includes: Zentalis Pharmaceuticals (NASDAQ:ZNTL), Replimune Group (NASDAQ:REPL) and ADC Therapeutics (NYSE:ADCT).
The latest price target for Precigen (NASDAQ: PGEN) was reported by Stifel on 2021-02-25. The analyst firm set a price target for 13.00 expecting PGEN to rise to within 12 months (a possible 53.85% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Precigen (NASDAQ: PGEN) is $8.45 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Precigen.
There is no upcoming split for Precigen.